Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F1GCS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $99,553
Award facts
- Contract value 100% obligated
- $99,553.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $99,553.23 on January 5, 2026, for the supply of ENBREL 50 mg/mL SureClick auto-injectors. The award was competitively procured with no set-aside designation and carries a firm fixed-price structure with an ultimate completion date of January 6, 2026. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contracting presence as a critical supplier to Defense Health Agency and other government healthcare systems. The company's extensive portfolio with the DLA encompasses a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains, demonstrating its capability to fulfill federal medical procurement requirements through open competition. This particular award for ENBREL—a biologic immunosuppressant used primarily for rheumatoid arthritis and other autoimmune conditions—reflects the contractor's ongoing role in supporting military medical supply chains with specialty medications and specialized delivery systems.
Quick answers
Who was awarded contract SPE2DR26F1GCS?
SPE2DR26F1GCS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F1GCS worth?
The government has obligated $99,553 on SPE2DR26F1GCS.
Is contract SPE2DR26F1GCS an order under another contract?
Yes. SPE2DR26F1GCS is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GCS competed?
The extent of competition for SPE2DR26F1GCS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award